Tranexamic Acid 500mg/5mL Injection

Tranexamic acid 500mg/5mL injection is an antifibrinolytic used to control or prevent bleeding associated with excessive breakdown of blood clots. It has a role in selected surgical, dental and other acute bleeding situations where intravenous treatment is appropriate. It reduces clot breakdown but does not remove the underlying cause of bleeding.
A healthcare professional administers this 100mg/mL solution slowly into a vein or by intravenous infusion. Rapid injection can cause low blood pressure. It must not be injected into muscle, the spinal canal or the epidural space. Kidney impairment requires a reduced dosing regimen.
Tranexamic acid inhibits fibrinolysis, helping prevent premature breakdown of blood clots at bleeding sites.
Possible effects include nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, fatigue, and visual symptoms. Serious concerns include blood clots, severe allergy, seizures at high exposure, and urinary obstruction from clots in selected bleeding sites.
Tell your doctor about blood clots, stroke, heart or kidney disease, bleeding from the urinary tract or colour-vision problems. Mention pregnancy, breastfeeding, hormonal contraception, clotting-factor products and anticoagulants. Unexplained irregular menstrual bleeding needs assessment of its cause.
Can reduce bleeding volume by preserving clots, helping control bleeding episodes without acting as a painkiller or hormone.
The full 5mL contains 500mg of tranexamic acid, equivalent to 100mg in each millilitre. It does not contain 500mg in every millilitre.
No. It reduces clot breakdown but does not diagnose or treat the underlying cause.
People with clot history, kidney disease, urinary-tract bleeding, color-vision problems, or hormonal contraception use need medical review.
Chest pain, breathlessness, leg swelling, sudden weakness, severe headache, vision changes, or low urine needs urgent care.
No. An intravenous bleeding-control regimen is selected for the acute clinical situation. An oral menstrual-bleeding schedule must not be transferred to this injection.
Antifibrinolytic: a medicine that slows clot breakdown. Fibrinolysis: the breakdown of fibrin within a blood clot. Haemostasis: control of bleeding. Thrombosis: formation of an unwanted clot inside a blood vessel. Renal clearance: removal of medicine through the kidneys.; AR: Tranexamic acid 500mg حقن; FR: Tranexamic acid 500mg injection; PT: Tranexamic acid 500mg injeção; ES: Tranexamic acid 500mg inyección; RU: Tranexamic acid 500mg инъекция; ID: Tranexamic acid 500mg injeksi; VI: Tranexamic acid 500mg thuốc tiêm; MS: Tranexamic acid 500mg suntikan; TL: Tranexamic acid 500mg iniksyon; ZH-SG: Tranexamic acid 500mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Tranexamic Acid 500mg/5mL Injection under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Tranexamic Acid 500mg/5mL Injection